Endurance RP (RPG) Stock Price & Analysis
RPG Stock Chart & Stats
- Day’s Range
- EUR 0.09 - EUR 0.09
- 52-Week Range
- EUR 0.06 - EUR 0.12
- Previous Close
- EUR 0.09
- Volume
- 0
- Average Volume (3M)
- 1
- Market Cap
- EUR 28.99M
- Enterprise Value
- EUR 359.35M
- Total Cash (Recent Filing)
- EUR 255.96K
- Total Debt (Recent Filing)
- EUR 7.36M
- Price to Earnings (P/E)
- ―
- Beta
- 1.48
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
High 2025 Gross Margin
The very high 2025 gross margin indicates that the company can retain substantial value from reported sales before operating costs. If maintained and paired with better expense control, this could provide operating leverage and support a path toward improved profitability, although the historical inconsistency limits confidence.
Improving Free Cash Flow Trend
Improvement in free cash flow versus 2024 suggests that cash consumption may be moderating, which could help preserve financial flexibility if the trend continues. However, the ongoing deficit means this is an incremental positive rather than evidence of self-funded growth or sustainable cash generation.
Reported EPS Growth
The reported 62.4% EPS growth rate is a positive directional signal and may indicate progress in per-share results over the measured period. Because the company remains loss-making and the pack also shows worsening net margins, this improvement should be treated as tentative rather than durable earnings strength.
Bears Say
Deepening Losses
Deteriorating net margins and materially negative EBIT and EBITDA show that the business is not converting revenue into operating or bottom-line profit. Persistent losses can consume capital, restrict reinvestment capacity, and make any recovery dependent on substantial operational improvement.
Revenue Volatility
A sharp revenue decline following earlier fluctuations makes the company’s earnings base difficult to forecast and weakens confidence in recurring demand. Unstable sales reduce planning visibility, make fixed costs harder to absorb, and can prevent strong gross margins from translating into dependable profitability.
Negative Equity And Leverage
Negative equity materially weakens the balance sheet and limits financial flexibility, while debt remains sizable relative to the reported asset base. This combination raises refinancing risk and leaves fewer internal resources available to absorb losses or fund business development.
RPG FAQ
What was Endurance RP’s price range in the past 12 months?
What is Endurance RP’s market cap?
When is Endurance RP’s upcoming earnings report date?
How were Endurance RP’s earnings last quarter?
Is Endurance RP overvalued?
Does Endurance RP pay dividends?
What is Endurance RP’s EPS estimate?
How many shares outstanding does Endurance RP have?
What happened to Endurance RP’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Endurance RP?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Endurance RP
Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treatments for urological disorders. It also invests in a portfolio of both listed and unlisted corporate entities.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Jamie Alexander Gibson
- Employees
- 17
- Website
- www.regentpac.com
- Address
- HK
Endurance RP (RPG) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 6 | 2 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 10 | 1 | 1 |
